News

Gender identity is no longer part of the Iowa Civil Rights Act. The change is part of a sweeping law that also defines a ...
Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.
Four Black students sat at a “whites only” lunch counter in 1960 and sparked the sit-in movement.
The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing an alternative treatment as opposed to traditional surgical procedures.
Even so, 30% of people with bladder cancer have no identifiable risk. Fortunately for you, a noninvasive cancer was found that was less than 3 cm, which is the best possible result for bladder cancer.
Leaders of the battle for civil rights in New Orleans are spotlighted in 'The Trail They Blazed' at the Historic New Orleans Collection.
There are new questions about who — in the rubber industry — is affected by bladder cancer. A former Sumitomo Rubber employee is coming forward and voicing concern about his diagnosis.
In a new study, published in Cancer Cell, Dr. Glickman and his colleagues showed BCG doesn't just work locally in the bladder, but reprograms and amplifies cells in the bone marrow that give rise ...
A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the ...
Join leading experts to discuss how we are ushering in a new era in bladder cancer care on May 28 virtually. Register now.
Abstract e16585 Background: The goal of neoadjuvant therapy for bladder cancer is to improve pathological outcomes and provide patients with the opportunity to preserve the bladder. Disitamab Vedotin, ...